Advancing Nuclear Medicine at the Multiomics Intersection: Johannes Czernin Discusses Innovation and Translation with Kalevi Kairemo

J Nucl Med. 2023 Nov;64(11):1671-1673. doi: 10.2967/jnumed.123.266793. Epub 2023 Oct 19.

Authors

Kalevi Kairemo¹, Johannes Czernin²

Affiliations

¹ Docrates Cancer Center, Helsinki, Finland (retired); and.
² David Geffen School of Medicine at UCLA, Los Angeles, California.

PMID: 37857505
DOI: 10.2967/jnumed.123.266793

No abstract available

MeSH terms

Leadership
Multiomics
Nuclear Medicine*
Radionuclide Imaging